Quantcast

Latest Personalized medicine Stories

2014-06-03 08:32:14

NEW YORK, June 3, 2014 /PRNewswire/ -- Exosome Diagnostics, a leading developer of non-invasive, biofluid-based molecular diagnostics, today announced that Vincent J. O'Neill, M.D., has been appointed as its chief medical officer. Dr. O'Neill has extensive experience in clinical trial design, regulatory issues, and personalized medicine, most recently as global head Personalized of Medicine and Companion Diagnostics at Sanofi. At Sanofi, he defined the personalized medicine...

2014-06-01 12:20:16

Diagnostic insights into gene mutations in solid tumor cancers will aid therapy selection and prognosis for patients and advance research NEW YORK and MADISON, N.J., June 1, 2014 /PRNewswire/ -- Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced a joint collaboration that will utilize MSK's clinical and research insights into...

2014-05-30 23:16:54

Dr. Bhubaneswar (Bud) Mishra joins InSilico Medicine Inc, a Baltimore-based bioinformatics and drug discovery company specializing in cancer and aging research and personalized medicine in age-related diseases. Baltimore, MD (PRWEB) May 30, 2014 InSilico Medicine, Inc, engaged in cancer and aging research for drug discovery and developing personalized approaches to extending productive longevity is proud to announce the addition of Prof. Bud Mishra to its board of scientific advisors....

2014-05-30 11:24:36

Georgia Institute of Technology A study of 338 patients with coronary artery disease has identified a gene expression profile associated with an elevated risk of cardiovascular death. Used with other indicators such as biochemical markers and family history, the profile – based on a simple blood test – may help identify patients who could benefit from personalized treatment and counseling designed to address risk factors. Researchers found the risk signature by comparing gene...

2014-05-28 23:12:12

Tissue diagnostics are an important set of techniques, primarily used for the diagnosis, monitoring and management of cancer. The report segments this market by technology, disease, product, end user and geography. http://www.marketsandmarkets.com/Market-Reports/tissue-diagnostics-market-1063949.html (PRWEB) May 28, 2014 The “Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer,...

2014-05-28 12:30:34

Strand celebrates the largest commercial adoption of genomics in cancer care to date ROCKVILLE, Md., May 28, 2014 /PRNewswire/ -- Strand Genomics Inc. (Strand), a global leader in clinical genomics, has announced a major initiative with Health Care Global Enterprises, Ltd (HCG) to provide personalized genomics services for oncology. Strand's clinical genomics solutions for oncology offered by the Strand-Triesta Center for Cancer Genomics (Strand-Triesta) include both cancer risk...

2014-05-27 23:05:12

Emerging biotech firm appoints prominent scientist/inventor as well as distinguished scientists/entrepreneurs to enhance scientific and business capabilities. Fayetteville, Ark., and Seattle, Wash. (PRWEB) May 27, 2014 Dr. Patricia Beckmann, a prominent scientist and inventor has been appointed to the combined roles of chief scientific officer (CSO) and chief business officer (CBO) at Ascendant Dx. In addition, Dr. Mark Boguski and Dr. Isaac Kohane have joined the Scientific Advisory...

2014-05-27 23:00:14

MarketReportsOnline.com adds "Deals in Oncology Personalized Medicine Industry - Worldwide Analysis" report to its research store. Place a direct purchase order at http://www.marketreportsonline.com/contacts/purchase.php?name=337367. Dallas, Texas (PRWEB) May 28, 2014 The Personalized Medicine in Oncology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the world’s leading...

2014-05-27 08:27:22

Future of DNA sequencing will shift from a laboratory-based setup to point of care testing in the next 5 years LONDON, May 27, 2014 /PRNewswire/ -- The Western European next-generation sequencing (NGS) market is poised for steady growth, owing to the emergence of new applications such as non-invasive prenatal testing and comprehensive oncology panels. NGS manufacturers are further tapping into this space by forming partnerships with molecular diagnostic companies to quicken NGS...

2014-05-23 08:24:42

ROCKVILLE, Md., May 23, 2014 /PRNewswire/ -- Strand Genomics Inc., a new generation healthcare innovation company headquartered in Bangalore, India, today announced that Ravi Venkatesan, the Chairman of Microsoft India from 2004-2011 who helped to build and expand Microsoft's position in India as the company's largest presence outside of the U.S., has joined the Strand Board of Directors. Mr. Venkatesan is the author of the acclaimed Conquering the Chaos: Win in India, Win Everywhere,...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related